Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GED for Lactase Expression in Duodenal Biopsies
NCT02902016Completed
- Sponsor
- CHU de Lille
- Start
- Jul 2015
- Primary completion
- Sep 2017
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
Open-label, single-arm trial of mongersen in lactose intolerance, sponsored by CHU de Lille. Primary endpoint: LCT mRNA expression in duodenal biopsies at 6 hours. Started Jul 2015; status: completed.
02
Drugs
mongersen
03
Conditions
lactose intolerance
Beyond the preview
Go deeper on NCT02902016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02902016.